Movement Alert｜Hyperliquid Strategies Inc Falls 9.32% in Regular Trading, Extending Post-Earnings Selloff Despite Record Fiscal Year Profit

Market Focus09-04 21:40

On September 4, Hyperliquid Strategies Inc fell 9.32% in regular trading, trading at $11.66/share, with turnover of $68.82 million. The decline extends a continued selloff following an 8.08% drop on September 2, despite the company reporting fiscal year net income of $305.5 million on August 27 — significantly beating analyst expectations of a $168.3 million net loss.

The company holds approximately $2.06 billion in total assets, with $1.9 billion concentrated in HYPE tokens, making its stock price highly sensitive to digital asset market fluctuations. On September 1, the company disclosed a first amendment to a purchase agreement via an SEC filing, though details remain limited. Earlier, Duquesne disclosed a new $23 million position in the stock as of June 30, signaling institutional interest.

Within the Biotechnology sector, Moderna fell 2.36%, Regeneron Pharmaceuticals fell 0.75%, AbbVie fell 0.75%, and Gilead Sciences fell 0.62%, while Immuron surged 69.36%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1119451246?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-04 21:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119451246","market":"us","top_or_hot":-1,"title":"Movement Alert｜Hyperliquid Strategies Inc Falls 9.32% in Regular Trading, Extending Post-Earnings Selloff Despite Record Fiscal Year Profit","media":"Market Focus","content":"<p><p>On September 4, Hyperliquid Strategies Inc fell 9.32% in regular trading, trading at $11.66/share, with turnover of $68.82 million. The decline extends a continued selloff following an 8.08% drop on September 2, despite the company reporting fiscal year net income of $305.5 million on August 27 — significantly beating analyst expectations of a $168.3 million net loss.</p><p>The company holds approximately $2.06 billion in total assets, with $1.9 billion concentrated in HYPE tokens, making its stock price highly sensitive to digital asset market fluctuations. On September 1, the company disclosed a first amendment to a purchase agreement via an SEC filing, though details remain limited. Earlier, Duquesne disclosed a new $23 million position in the stock as of June 30, signaling institutional interest.</p><p>Within the Biotechnology sector, Moderna fell 2.36%, Regeneron Pharmaceuticals fell 0.75%, AbbVie fell 0.75%, and Gilead Sciences fell 0.62%, while Immuron surged 69.36%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Hyperliquid Strategies Inc Falls 9.32% in Regular Trading, Extending Post-Earnings Selloff Despite Record Fiscal Year Profit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Hyperliquid Strategies Inc Falls 9.32% in Regular Trading, Extending Post-Earnings Selloff Despite Record Fiscal Year Profit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-04 21:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 4, Hyperliquid Strategies Inc fell 9.32% in regular trading, trading at $11.66/share, with turnover of $68.82 million. The decline extends a continued selloff following an 8.08% drop on September 2, despite the company reporting fiscal year net income of $305.5 million on August 27 — significantly beating analyst expectations of a $168.3 million net loss.</p><p>The company holds approximately $2.06 billion in total assets, with $1.9 billion concentrated in HYPE tokens, making its stock price highly sensitive to digital asset market fluctuations. On September 1, the company disclosed a first amendment to a purchase agreement via an SEC filing, though details remain limited. Earlier, Duquesne disclosed a new $23 million position in the stock as of June 30, signaling institutional interest.</p><p>Within the Biotechnology sector, Moderna fell 2.36%, Regeneron Pharmaceuticals fell 0.75%, AbbVie fell 0.75%, and Gilead Sciences fell 0.62%, while Immuron surged 69.36%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PURR","symbol_name":"Hyperliquid Strategies Inc","start_time":0,"source_url":"","article_id":"1119451246","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119451246","pubTimestamp":1788529255,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 4, Hyperliquid Strategies Inc fell 9.32% in regular trading, trading at $11.66/share, with turnover of $68.82 million. The decline extends a continued selloff following an 8.08% drop on...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PURR":"Hyperliquid Strategies Inc"},"translate_title":"走势警报|Hyperliquid Strategies Inc 在常规交易中下跌 9.32%，尽管财年利润创历史新高，但财报后抛售仍在延长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PURR":1},"content_text":"On September 4, Hyperliquid Strategies Inc fell 9.32% in regular trading, trading at $11.66/share, with turnover of $68.82 million. The decline extends a continued selloff following an 8.08% drop on September 2, despite the company reporting fiscal year net income of $305.5 million on August 27 — significantly beating analyst expectations of a $168.3 million net loss.The company holds approximately $2.06 billion in total assets, with $1.9 billion concentrated in HYPE tokens, making its stock price highly sensitive to digital asset market fluctuations. On September 1, the company disclosed a first amendment to a purchase agreement via an SEC filing, though details remain limited. Earlier, Duquesne disclosed a new $23 million position in the stock as of June 30, signaling institutional interest.Within the Biotechnology sector, Moderna fell 2.36%, Regeneron Pharmaceuticals fell 0.75%, AbbVie fell 0.75%, and Gilead Sciences fell 0.62%, while Immuron surged 69.36%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1119451246","isCrawlerRequest":true}